by GCP Central | jan 31, 2022 | GCP Central News
Today’s the day the EU CTR comes into effect. This new legislation will majorly impact organizations involved in the design and implementation of clinical trials. Our previous blog covered the fundamentals of this new regulation and what made it different from...
by GCP Central | jan 26, 2022 | GCP Central Products
On the 31st of January, 2022, the European Commission’s new clinical trial legislation will come into effect. With the hope of creating a better environment to conduct clinical trials within the EU, the European Clinical Trials Regulation (EU CTR...
by GCP Central | dec 13, 2021 | GCP Central News
On November 1, 2021, the new Local Feasibility Procedure and the use of the Research Institute Suitability Statement (VGO) will be in place. This is mandatory for drug research. We spoke with Sanofi’s Thera Max-Mos, Head Clinical Study Unit ai, NL, to...
by GCP Central | apr 20, 2021 | GCP Central News
We’re proud to announce that Marieke Meulemans will present “ European Clinical Trial Regulation (ECTR) and Medical Device Regulation (MDR)” on April 21st, 2021, with co-panelists Rianne Tooten and Isabelle van der Haegen. This session will be held between...
by GCP Central | mrt 15, 2021 | GCP Central News, GCP Central Products
With the constant increase of our e-learner base, we think of ways to accommodate your different learning and compliance needs. This is why we recently launched our new Refresher ICH GCP Course for Clinical Drug Trials in Germany. Our Refresher ICH GCP Course is...
by GCP Central | jan 26, 2021 | GCP Central News, GCP Central Products
With the start of the new year, we launched our new Good Manufacturing Practice (GMP) online course that covers the legal requirements and best practices for quality oversight on external manufacturing. The GMP quality oversight course for European drug products is a...
